Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.
BIOCON LTD has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Sep-17* | 3 Jun-18* | 3 Sep-18* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 9,686 | 11,238 | 13,210 | 17.5% | 36.4% |
Other income | Rs m | 508 | 688 | 544 | -20.9% | 7.1% |
Turnover | Rs m | 10,194 | 11,926 | 13,754 | 15.3% | 34.9% |
Expenses | Rs m | 7,863 | 8,860 | 9,814 | 10.8% | 24.8% |
Gross profit | Rs m | 1,620 | 2,378 | 5,284 | 122.2% | 226.2% |
Depreciation | Rs m | 936 | 991 | 1,122 | 13.2% | 19.9% |
Interest | Rs m | 138 | 176 | 188 | 6.8% | 36.2% |
Profit before tax | Rs m | 1,054 | 1,899 | 4,518 | 137.9% | 328.7% |
Tax | Rs m | 425 | 521 | 732 | 40.5% | 72.2% |
Profit after tax | Rs m | 629 | 1,378 | 3,786 | 174.7% | 501.9% |
Gross profit margin | % | 16.7 | 21.2 | 40.0 | ||
Effective tax rate | % | 40.3 | 27.4 | 16.2 | ||
Net profit margin | % | 6.2 | 11.6 | 27.5 |
To see how BIOCON LTD has performed over the last eight quarters, please visit here.
Over the last one year, BIOCON LTD share price has moved up from Rs 400.7 to Rs 636.5, registering a Gain of Rs 235.9 or around 58.9%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,681.6 (up 1.0%). Over the last one year it has moved up from 13,987.8 to 14,681.6, a gain of 694 points (up 5.0%).
Overall, the S&P BSE SENSEX is up 5.3% over the year.
At the current price of Rs 636.5, the price to earnings (P/E) ratio of BIOCON LTD stands at 50.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.4 times.
| |
For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.
For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.
Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.
Net Profit lower due to exceptional items in the previous year.
Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsThe real estate sector is ready to make a comeback. This is the stock to consider buying.
During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.
This is the trick to following super investors and not losing money.
Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.
Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.
More
| |
Equitymaster requests your view! Post a comment on "BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!